Skip to content

A Study of Cognitive Health in Survivors of Prostate Cancer

Prostate Cancer Survivorship and Cognitive Health (PRO-HEALTH)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05540782
Enrollment
200
Registered
2022-09-15
Start date
2022-09-08
Completion date
2026-09-08
Last updated
2025-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer, Survivorship

Keywords

Cognitive health, Quality of Life, 22-223

Brief summary

The purpose of this study is to collect information that may help the researchers understand the relationship between prostate cancer survivors' experiences of cancer-related cognitive dysfunction (CRCD) and their other conditions (co-morbid factors), including anxiety, depression, and insomnia. The researchers will also find out how additional things may contribute to CRCD, including social factors, the characteristics of participants' prostate cancer, and the type of cancer treatment or other medications they received.

Interventions

BEHAVIORALPROMIS-SF v2.0 -Cognitive Function 8a

Patient-Reported Outcomes (PROs)

Sponsors

Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum

Inclusion criteria

* English-speaking * Age 18 years or older * History of histologically documented PC of any stage * No evidence of PC Disease

Exclusion criteria

* \<1 month since completion of surgery, radiation, chemotherapy, or ADT * Diagnosis of Alzheimer's disease, vascular dementia, Parkinson disease, or other organic brain disorder * Score \>10 indicative of dementia on Blessed Orientation Memory Concentration

Design outcomes

Primary

MeasureTime frameDescription
number of participants with co-morbid symptoms1 yearAll participants will be evaluable as long as they have completed the PROMIS-SF v2.0 - Cognitive Function 8a.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026